At Abbott, we are committed to safeguarding a healthy environment by reducing the environmental impacts of our business. We have established ambitious 2020 targets to significantly reduce our carbon dioxide emissions, waste, and water use. Abbott’s Energy Policy sets aggressive goals to further reduce our environmental footprint, including our commitments to dramatically reducing CO2 e emissions. At Abbott, we are committed to building awareness and improving diagnosis. With relentless focus and efforts, we strive to improve healthcare and drive awareness building and diagnosis improvement through education and diagnostic camps, addressing the need for better healthcare, diagnostic and sanitation facilities. Abbott’s dedication to supporting communities is shown through our employees’ passion for giving back. Whether it is sharing scientific expertise, or volunteering time to provide nutritious meals to families in need, or preparing our communities before disaster strikes, we are helping communities to be more resilient. Leveraging our employees’ skills and time, we are addressing societal issues that are affecting the communities where we live and work. A majority of the directors shall meet the New York Stock Exchange listing standards for independence, as such requirements are interpreted by the board in its business judgment. All of the members of the audit committee, compensation committee, the nominations and governance committee, and the public policy committee shall be independent. The qualifications for Abbott’s directors are set forth in the Outline for Directorship Qualifications, which is attached as Exhibit A. Directors are expected to report to the chairman of the board and the chairman of the nominations and governance committee when they experience a significant change in their business or professional affiliation or responsibility and offer to resign from the board. The nominations and governance committee, in consultation with the chairman of the board, will determine whether the director continues to adequately meet the requirements for service on the board of directors and whether or not to accept the resignation. Abbott’s diagnostic testing solutions serve laboratory and point-of-care needs, playing a pivotal role in its financial performance. The company’s nutritional products, including infant formula and adult supplements, provide consistent revenue. Operating worldwide enables Abbott to tap into various markets and adapt to diverse healthcare demands. Abbott’s commitment to research and development drives innovation, introducing new products and maintaining competitiveness. Navigating strict healthcare regulations underpins Abbott’s ability to launch products successfully.